Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus.

Kasturiratne A, Weerasinghe S, Dassanayake AS, Rajindrajith S, de Silva AP, Kato N, Wickremasinghe AR, de Silva HJ.

J Gastroenterol Hepatol. 2013 Jan;28(1):142-7. doi: 10.1111/j.1440-1746.2012.07264.x.

PMID:
22989165
2.

Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.

Ming J, Xu S, Gao B, Liu G, Ji Y, Yang F, Jia Y, Fang Y, Ji Q.

Liver Int. 2015 Nov;35(11):2401-7. doi: 10.1111/liv.12851. Epub 2015 May 5.

PMID:
25879672
3.

Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.

Chang Y, Jung HS, Yun KE, Cho J, Cho YK, Ryu S.

Am J Gastroenterol. 2013 Dec;108(12):1861-8. doi: 10.1038/ajg.2013.349. Epub 2013 Oct 8.

PMID:
24100261
4.

Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up.

Zelber-Sagi S, Lotan R, Shibolet O, Webb M, Buch A, Nitzan-Kaluski D, Halpern Z, Santo E, Oren R.

Liver Int. 2013 Oct;33(9):1406-12. doi: 10.1111/liv.12200. Epub 2013 May 8.

PMID:
23656177
5.

Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka.

Perera N, Indrakumar J, Abeysinghe WV, Fernando V, Samaraweera WM, Lawrence JS.

BMC Cardiovasc Disord. 2016 Feb 12;16:37. doi: 10.1186/s12872-016-0212-8.

7.
8.

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.

Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ.

J Gastroenterol Hepatol. 2009 Jul;24(7):1284-8. doi: 10.1111/j.1440-1746.2009.05831.x. Epub 2009 May 19.

PMID:
19476560
9.

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, Hardies J, Cusi K.

Diabetes Care. 2012 Apr;35(4):873-8. doi: 10.2337/dc11-1849. Epub 2012 Feb 28.

10.

NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.

Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK.

Am J Gastroenterol. 2009 Apr;104(4):861-7. doi: 10.1038/ajg.2009.67. Epub 2009 Mar 17.

PMID:
19293782
11.

Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.

Zelber-Sagi S, Salomone F, Yeshua H, Lotan R, Webb M, Halpern Z, Santo E, Oren R, Shibolet O.

Liver Int. 2014 Jul;34(6):e128-35. doi: 10.1111/liv.12318. Epub 2013 Oct 14.

PMID:
24118857
12.
13.

Interaction of type 2 diabetes and nonalcoholic fatty liver disease.

Verderese JP, Younossi Z.

Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):405-7. doi: 10.1586/17474124.2013.811047.

PMID:
23899279
14.

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.

Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Rodella S, Zoppini G, Mantovani W, Barbieri E, Byrne CD.

PLoS One. 2013;8(2):e57183. doi: 10.1371/journal.pone.0057183. Epub 2013 Feb 22.

15.

Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.

Kotronen A, Yki-Järvinen H, Männistö S, Saarikoski L, Korpi-Hyövälti E, Oksa H, Saltevo J, Saaristo T, Sundvall J, Tuomilehto J, Peltonen M.

BMC Public Health. 2010 May 10;10:237. doi: 10.1186/1471-2458-10-237.

16.

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA.

Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19.

PMID:
20858492
17.

Risk factors for non-alcoholic fatty liver disease in a Chinese population.

He S, Bao W, Shao M, Wang W, Wang C, Sun J, Jiang Y, Feng X, Niu J.

Acta Gastroenterol Belg. 2011 Dec;74(4):503-8.

PMID:
22319959
18.

Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).

Kalra S, Vithalani M, Gulati G, Kulkarni CM, Kadam Y, Pallivathukkal J, Das B, Sahay R, Modi KD.

J Assoc Physicians India. 2013 Jul;61(7):448-53.

PMID:
24772746
19.

Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.

Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS.

Diabetes Res Clin Pract. 2009 Apr;84(1):84-91. doi: 10.1016/j.diabres.2008.11.039. Epub 2009 Jan 24.

PMID:
19168251
20.

Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.

Yamazaki H, Tsuboya T, Tsuji K, Dohke M, Maguchi H.

Diabetes Care. 2015 Sep;38(9):1673-9. doi: 10.2337/dc15-0140. Epub 2015 Jul 8.

PMID:
26156527

Supplemental Content

Support Center